Jin Medical International Ltd.(ZJYL)Earnings, Financials & Key Ratios
ZJYL•NASDAQ
$1.91
12.7× P/E·Price updated Jul 7, 2026
AboutJin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.Show more
- Revenue$21M-12.0%
- EBITDA$933K-76.6%
- Net Income$1M-67.6%
- EPS (Diluted)0.15-68.1%
- Gross Margin29.22%-27.7%
- EBITDA Margin4.51%-73.4%
- Operating Margin2.94%-81.0%
- Net Margin5.76%-63.2%
- ROE4.1%-70.7%
ZJYL Price & Volume
Jin Medical International Ltd. (ZJYL) stock price & volume — 10-year historical chart
Loading chart...
Rising Debt and Volatile Margins Cloud Outlook
Investment Thesis • Updated 2025Q4
VerdictNegative: The company's inability to convert accounting profits into cash
Growth:Decelerating
Profitability:Strained
Financial:Vulnerable
Cash Flow:Mixed
Primary Risk:Export market demand volatility
Key Thesis Takeaways
- Jin Medical International faces significant headwinds as its export-heavy business model struggles with a 16.5% revenue contraction in 2025Q4 and inconsistent operating margins.
- The company's aggressive shift toward debt-funded capital expansion, evidenced by a surge in total debt to $18.9 million, has yet to yield sustainable operational improvements.
- Investors should remain cautious as the firm's reliance on non-operating income to bolster its 11.8% net margin suggests underlying core profitability remains fragile.
Verdict Logic
highlighted by a 0.27 OCF/NI ratio, combined with a rapid escalation in debt to $18.9 million, presents an unfavorable risk-reward profile.
ZJYL Growth Metrics
Jin Medical International Ltd. (ZJYL) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years5.02%
3 Years2.53%
TTM13.27%
Profit CAGR
10 Years-
5 Years-11.59%
3 Years-23.93%
TTM-12.85%
EPS CAGR
10 Years-
5 Years6.4%
3 Years-27.89%
TTM-23.19%
Return on Capital
10 Years22.48%
5 Years13.26%
3 Years10.18%
Last Year2.09%
ZJYL Recent Earnings
Jin Medical International Ltd. (ZJYL) EPS & revenue vs analyst estimates — last 1 quarters
Q1 2026Latest
Jan 23, 2026Metric
Actual
Est
EPS
$0.16
—
Rev
$11M
—
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Jan 23, 2026 | $0.16 | $11M |
Based on last 1 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for Jin Medical International Ltd. (ZJYL)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $1.91 | $14.95M | 12.73 | -11.98% | 5.76% | 4.1% | — | |
| $1272.81 | $62.53B | 99.83 | 26.43% | 22.84% | 19.05% | — | |
| $17.72 | $2.02B | -14.52 | 8.28% | -25.66% | -50.82% | — | |
| $404.36 | $10.23B | -139.43 | 8.92% | -1.61% | -1.57% | — | |
| $150.65 | $8.82B | -45.93 | 32.33% | -34.34% | -26.46% | — | |
| $22.25 | $1.64B | 6.74 | 18.52% | 118.91% | 47.59% | — |
Compare ZJYL vs Peers
Jin Medical International Ltd. (ZJYL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when ZJYL posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
ZJYL Frequently Asked Questions
Jin Medical International Ltd. (ZJYL) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Jin Medical International Ltd.'s revenue?
Jin Medical International Ltd. (ZJYL) reported $44.2M in revenue for fiscal year 2025. This represents a 111% increase from $20.9M in 2018.
How fast is Jin Medical International Ltd. growing?
Jin Medical International Ltd. (ZJYL) saw revenue decline by 12.0% over the past year.
Is ZJYL profitable?
Yes, Jin Medical International Ltd. (ZJYL) is profitable, generating $4.9M in net income for fiscal year 2025 (5.8% net margin).
Dividend & Returns
What is ZJYL's return on equity?
Jin Medical International Ltd. (ZJYL) has a return on equity (ROE) of 4.1%. This is below average, suggesting room for improvement.
What is Jin Medical International Ltd.'s free cash flow?
Jin Medical International Ltd. (ZJYL) had negative free cash flow of $5.1M in fiscal year 2025, likely due to heavy capital investments.